Senior insider sale
EVP & Chief Medical Officer at ASCENDIS PHARMA A/S — senior position signals high conviction
$1.74M
7.29K shares
What this filing means
SHU AIMEE plans to sell 7.29K shares of ASCENDIS PHARMA A/S valued at approximately $1.74M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/4/2026ACC: 0001973379-26-000078
Officer· EVP & Chief Medical Officer
Since Mar 2026
7.29K
Shares to sell
$1.74M
Approx. market value
7.29K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
SHARE PLAN ACCOUNT
COMPENSATION
3/4/2026
7.29KTotal acquired7.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2026 | SHARE PLAN ACCOUNT COMPENSATION | 7.29K | — |
| Total | 7.29K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.29K
Market value
$1.74M
3/4/2026
Total
Units
7.29K
Value
$1.74M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/4/2026 | 7.29K | $1.74M | NASDAQ | Planned |
| Total | 7.29K | $1.74M | ||